Skip to content
BT
Company

Updated:

BIOSPECIFICS TECHNOLOGIES CORP

BIOSPECIFICS TECHNOLOGIES CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000875622, and its reported...

Overview

BIOSPECIFICS TECHNOLOGIES CORP is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000875622, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2020-03-16, it reported annual revenue of USD 38,187,755; net income of USD 24,469,808; total assets of USD 126,653,268 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
BIOSPECIFICS TECHNOLOGIES CORP
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Lynbrook, NY, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0000875622

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2019USD$38.2M$24.5M$126.7M$5.0M$22.3M
FY2018USD$33.0M$20.1M$100.1M$13.2M$17.7M
FY2017USD$27.4M$11.3M$75.0M$7.3M$13.2M
FY2016USD$26.3M$11.4M$64.7M$4.8M—

Recent SEC filings

FormFiledPeriodFiling
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
SC 13D—SC 13D
SC 13D—SC 13D
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
8-KFORM 8-K
10-Q10-Q
8-KFORM 8-K
8-KFORM 8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research BIOSPECIFICS TECHNOLOGIES CORP in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

BIOSPECIFICS TECHNOLOGIES CORP | Lynbrook Company | Altss